Neurocrine Biosciences Inc (NAS:NBIX)
$ 142 3.52 (2.54%) Market Cap: 14.29 Bil Enterprise Value: 13.24 Bil PE Ratio: 39.12 PB Ratio: 5.99 GF Score: 89/100

Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 05:20PM GMT
Release Date Price: $97.01 (+1.84%)
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Welcome, everybody. My name is Chris Shibutani. I'm the newest member of the Goldman Sachs Biotech Equity Research team. Thank you for joining us for our 42nd Annual Healthcare Conference, virtual, hopefully, the last time we'd do a virtual one. Very happy to have joining us, Kevin Gorman, CEO of Neurocrine Biosciences. Kevin, thanks for joining us today.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Thank you for the opportunity, Chris, and thanks to Goldman Sachs also. And I'm with you. I do hope this is the last virtual time around. I much more enjoyed being in person with everyone.

Questions & Answers

Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Terrific. Yes. No. And I love that you're at your desk, coffee cup, the whole backdrop there. This is total workshop, Kevin, which I think a lot of people who know you. There's no fuss, no muss. Sleeves are -- sleeves should

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot